{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T19:36:38Z","timestamp":1774899398020,"version":"3.50.1"},"reference-count":113,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.cjca.2014.09.032","type":"journal-article","created":{"date-parts":[[2014,10,4]],"date-time":"2014-10-04T10:53:26Z","timestamp":1412420006000},"page":"S442-S454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"S","title":["The Epidemic of Heart Failure: A Lucid Approach to Stemming the Rising Tide"],"prefix":"10.1016","volume":"30","author":[{"given":"Eileen","family":"O'Meara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0973-206X","authenticated-orcid":false,"given":"Nicolas","family":"Thibodeau-Jarry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anique","family":"Ducharme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Lucien","family":"Rouleau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2014.09.032_bib1","first-page":"1265","article-title":"Regional variation in self-reported heart disease prevalence in Canada","volume":"21","author":"Chow","year":"2005","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2014.09.032_bib2","first-page":"430","article-title":"On the rise: the current and projected future burden of congestive heart failure hospitalization in Canada","volume":"19","author":"Johansen","year":"2003","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2014.09.032_bib3","doi-asserted-by":"crossref","first-page":"E765","DOI":"10.1503\/cmaj.111958","article-title":"Trends in the incidence and outcomes of heart failure in Ontario, Canada: 1997 to 2007","volume":"184","author":"Darwin","year":"2012","journal-title":"CMAJ"},{"key":"10.1016\/j.cjca.2014.09.032_bib4","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/eurheartj\/eht066","article-title":"Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND","volume":"34","author":"Brouwers","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2014.09.032_bib5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2174\/1573403X11309020006","article-title":"Heart failure in North America","volume":"9","author":"Blair","year":"2013","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.cjca.2014.09.032_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejheart.2004.04.011","article-title":"Heart failure after myocardial infarction: clinical presentation and survival","volume":"7","author":"Hellermann","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2014.09.032_bib7","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1161\/01.CIR.0000039105.49749.6F","article-title":"Lifetime risk for developing congestive heart failure: the Framingham Heart Study","volume":"106","author":"Lloyd-Jones","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.09.032_bib8","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.numecd.2004.10.002","article-title":"Insulin resistance, dietary fat intake and blood pressure predict left ventricular diastolic function 20 years later","volume":"15","author":"Arnlov","year":"2005","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.cjca.2014.09.032_bib9","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1067\/mhj.2001.116957","article-title":"Several factors associated with the insulin resistance syndrome are predictors of left ventricular systolic dysfunction in a male population after 20 years of follow-up","volume":"142","author":"Arnlov","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2014.09.032_bib10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa020245","article-title":"Obesity and the risk of heart failure","volume":"347","author":"Kenchaiah","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2014.09.032_bib11","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.ehj.2004.06.038","article-title":"Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study","volume":"25","author":"Bleumink","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2014.09.032_bib12","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archinte.161.7.996","article-title":"Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study","volume":"161","author":"He","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cjca.2014.09.032_bib13","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1001\/jama.2009.1062","article-title":"Relation between modifiable lifestyle factors and lifetime risk of heart failure","volume":"302","author":"Djousse","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2014.09.032_bib14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/jama.2013.7588","article-title":"Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial","volume":"310","author":"Ledwidge","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2014.09.032_bib15","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.jacc.2005.11.084","article-title":"Renal impairment and outcomes in heart failure: systematic review and meta-analysis","volume":"47","author":"Smith","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.09.032_bib16","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1093\/eurheartj\/ehm037","article-title":"How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology","volume":"28","author":"Paulus","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2014.09.032_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehu204","article-title":"New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes","author":"Senni","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2014.09.032_bib18","doi-asserted-by":"crossref","first-page":"E27","DOI":"10.1097\/JCN.0b013e3181ee5fb2","article-title":"Educational interventions for patients with heart failure: a systematic review of randomized controlled trials","volume":"26","author":"Boyde","year":"2011","journal-title":"J\u00a0Cardiovasc Nurs"},{"key":"10.1016\/j.cjca.2014.09.032_bib19","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/eurheartj\/ehr354","article-title":"Person-centred care: more than just improving patient satisfaction?","volume":"33","author":"Cowie","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2014.09.032_bib20","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/eurheartj\/ehr306","article-title":"Effects of person-centred care in patients with chronic heart failure: the PCC-HF study","volume":"33","author":"Ekman","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2014.09.032_bib21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/heartjnl-2012-302313","article-title":"Specialist clinics for reducing emergency admissions in patients with heart failure: a systematic review and meta-analysis of randomised controlled trials","volume":"99","author":"Thomas","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2014.09.032_bib22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1503\/cmaj.1041137","article-title":"Impact of care at a multidisciplinary congestive heart failure clinic: a randomized trial","volume":"173","author":"Ducharme","year":"2005","journal-title":"CMAJ"},{"key":"10.1016\/j.cjca.2014.09.032_bib23","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jacc.2007.10.061","article-title":"Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study","volume":"51","author":"Bourge","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"suppl 1","key":"10.1016\/j.cjca.2014.09.032_bib24","doi-asserted-by":"crossref","first-page":"i40","DOI":"10.1093\/europace\/eut105","article-title":"Disease management: remote monitoring in heart failure patients with implantable defibrillators, resynchronization devices, and haemodynamic monitors","volume":"15","author":"Abraham","year":"2013","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2014.09.032_bib25","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0140-6736(11)60101-3","article-title":"Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial","volume":"377","author":"Abraham","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2014.09.032_bib26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.hrtlng.2007.04.004","article-title":"Telehome monitoring in patients with cardiac disease who are at high risk of readmission","volume":"37","author":"Woodlend","year":"2008","journal-title":"Heart Lung"},{"key":"10.1016\/j.cjca.2014.09.032_bib27","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1200\/JCO.2009.26.3756","article-title":"American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor\u2013positive breast cancer","volume":"28","author":"Burstein","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cjca.2014.09.032_bib28","series-title":"Acute Coronary Syndromes: A companion to Braunwald's Heart Disease","first-page":"81","article-title":"Pharmacogenomics","author":"de Denus","year":"2011"},{"key":"10.1016\/j.cjca.2014.09.032_bib29","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2217\/pgs.12.197","article-title":"An evaluation of pharmacists' expectations towards pharmacogenomics","volume":"14","author":"de Denus","year":"2013","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.cjca.2014.09.032_bib30","doi-asserted-by":"crossref","first-page":"e000110","DOI":"10.1136\/bmjopen-2011-000110","article-title":"Personalised medicine in Canada: a survey of adoption and practice in oncology, cardiology and family medicine","volume":"1","author":"Bonter","year":"2011","journal-title":"BMJ Open"},{"key":"10.1016\/j.cjca.2014.09.032_bib31","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/j.ijcard.2013.08.042","article-title":"Metabolomic fingerprint of heart failure in humans: a nuclear magnetic resonance spectroscopy analysis","volume":"168","author":"Tenori","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2014.09.032_bib32","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.clinbiochem.2010.11.010","article-title":"1H nuclear magnetic resonance based metabolic urinary profiling of patients with ischemic heart failure","volume":"44","author":"Kang","year":"2011","journal-title":"Clin Biochem"},{"key":"10.1016\/j.cjca.2014.09.032_bib33","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.echo.2007.05.008","article-title":"Prognostic implications of relations of left ventricular systolic dysfunction with body composition and myocardial energy expenditure: the Strong Heart Study","volume":"21","author":"Palmieri","year":"2008","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.cjca.2014.09.032_bib34","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/CIRCULATIONAHA.111.060368","article-title":"Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function","volume":"126","author":"Shah","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.09.032_bib35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1373\/clinchem.2011.169573","article-title":"Metabolomics and cardiovascular biomarker discovery","volume":"58","author":"Rhee","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.cjca.2014.09.032_bib36","doi-asserted-by":"crossref","first-page":"e88102","DOI":"10.1371\/journal.pone.0088102","article-title":"1H-NMR-based metabolic analysis of human serum reveals novel markers of myocardial energy expenditure in heart failure patients","volume":"9","author":"Du","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cjca.2014.09.032_bib37","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ahj.2009.06.018","article-title":"Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials","volume":"158","author":"Felker","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2014.09.032_bib38","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/archinternmed.2010.35","article-title":"B-type natriuretic peptide-guided heart failure therapy: a meta-analysis","volume":"170","author":"Porapakkham","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cjca.2014.09.032_bib39","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/CIRCULATIONAHA.111.044149","article-title":"Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: data from 2 large randomized clinical trials","volume":"125","author":"Masson","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.09.032_bib40","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/CIRCHEARTFAILURE.113.000450","article-title":"Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial","volume":"7","author":"Gravning","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjca.2014.09.032_bib41","unstructured":"Ahmad T, Fiuzat M, Pencina MJ, et\u00a0al. Charting a roadmap for heart failure biomarker studies [e-pub ahead of print]. JACC Heart Fail http:\/\/dx.doi.org\/10.1016\/j.jchf.2014.02.005.2014. Accessed: September 17, 2014."},{"key":"10.1016\/j.cjca.2014.09.032_bib42","doi-asserted-by":"crossref","first-page":"e000083","DOI":"10.1161\/JAHA.112.000083","article-title":"Prospective observational study of implantable cardioverter-defibrillators in primary prevention of sudden cardiac death: study design and cohort description","volume":"2","author":"Cheng","year":"2013","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.cjca.2014.09.032_bib43","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jcmg.2013.12.014","article-title":"LGE and NT-proBNP identify low risk of death or arrhythmic events in patients with primary prevention ICDs","volume":"7","author":"Mordi","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2014.09.032_bib44","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jacc.2012.12.016","article-title":"Nitroso-redox imbalance affects cardiac structure and function","volume":"61","author":"Karantalis","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.09.032_bib45","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.jacc.2008.01.068","article-title":"Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study","volume":"51","author":"Hare","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.09.032_bib46","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/0002-8703(88)90883-6","article-title":"Abnormal coronary hemodynamics and myocardial energetics in patients with chronic heart failure caused by ischemic heart disease and dilated cardiomyopathy","volume":"115","author":"De Marco","year":"1988","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2014.09.032_bib47","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/1479164112441526","article-title":"GLP-1 receptor agonists: a clinical perspective on cardiovascular effects","volume":"9","author":"Mundil","year":"2012","journal-title":"Diabetes Vasc Dis Res"},{"key":"10.1016\/j.cjca.2014.09.032_bib48","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2014.09.032_bib49","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr244","article-title":"Seeking new heights in acute heart failure syndromes: lessons from ASCEND and EVEREST","volume":"34","author":"Konstam","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2014.09.032_bib50","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/eurheartj\/ehn156","article-title":"Diabetes, left ventricular systolic dysfunction, and chronic heart failure","volume":"29","author":"MacDonald","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2014.09.032_bib51","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/eurjhf\/hfq154","article-title":"EURObservational Research Programme: the Heart Failure Pilot Survey (ESC-HF Pilot)","volume":"12","author":"Maggioni","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2014.09.032_bib52","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs033","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2014.09.032_bib53","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1002\/cmdc.201200081","article-title":"Discovery of BAY 94-8862: a nonsteroidal antagonist of the mineralocorticoid receptor for the treatment of cardiorenal diseases","volume":"7","author":"Barfacker","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.cjca.2014.09.032_bib54","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1093\/eurheartj\/eht187","article-title":"Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial","volume":"34","author":"Pitt","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2014.09.032_bib55","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin\u2013neprilysin inhibition versus Enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2014.09.032_bib56","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A\u00a0novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.09.032_bib57","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.healun.2012.09.009","article-title":"Effects of chronic sildenafil use on pulmonary hemodynamics and clinical outcomes in heart transplantation","volume":"31","author":"Pons","year":"2012","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.cjca.2014.09.032_bib58","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cjca.2011.09.018","article-title":"Hemodynamic and clinical benefits associated with chronic sildenafil therapy in advanced heart failure: experience of the Montreal Heart Institute","volume":"28","author":"Potter","year":"2012","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2014.09.032_bib59","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/jama.2013.2024","article-title":"Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial","volume":"309","author":"Redfield","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2014.09.032_bib60","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0735-1097(02)02968-6","article-title":"Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study","volume":"41","author":"Felker","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.09.032_bib61","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/2048872612457044","article-title":"Treating volume overload in acutely decompensated heart failure: established and novel therapeutic approaches. European heart journal","volume":"1","author":"Koniari","year":"2012","journal-title":"Acute Cardiovascular Care"},{"key":"10.1016\/j.cjca.2014.09.032_bib62","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1126\/science.1200113","article-title":"Cardiac myosin activation: a potential therapeutic approach for systolic heart failure","volume":"331","author":"Malik","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.cjca.2014.09.032_bib63","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0140-6736(11)61126-4","article-title":"The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial","volume":"378","author":"Cleland","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2014.09.032_bib64","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00395-009-0057-8","article-title":"K201 improves aspects of the contractile performance of human failing myocardium via reduction in Ca2+ leak from the sarcoplasmic reticulum","volume":"105","author":"Toischer","year":"2010","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.cjca.2014.09.032_bib65","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1161\/CIRCRESAHA.111.259754","article-title":"Modulation of cardiac contractility by the phospholamban\/SERCA2a regulatome","volume":"110","author":"Kranias","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2014.09.032_bib66","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/CIR.0b013e3182456d46","article-title":"Executive summary: heart disease and stroke statistics\u20132012 update: a report from the American Heart Association","volume":"125","author":"Roger","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.09.032_bib67","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1161\/CIRCULATIONAHA.107.696906","article-title":"Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure","volume":"116","author":"Solomon","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.09.032_bib68","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa0912613","article-title":"Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure","volume":"363","author":"Massie","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2014.09.032_bib69","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1100171","article-title":"Effect of nesiritide in patients with acute decompensated heart failure","volume":"365","author":"O'Connor","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2014.09.032_bib70","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1001\/jama.2013.282190","article-title":"Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial","volume":"310","author":"Chen","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2014.09.032_bib71","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1093\/eurheartj\/ehl337","article-title":"Haemodynamic and clinical effects of ularitide in decompensated heart failure","volume":"27","author":"Mitrovic","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2014.09.032_bib72","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11897-010-0010-z","article-title":"Relaxin: review of biology and potential role in treating heart failure","volume":"7","author":"Teichman","year":"2010","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.cjca.2014.09.032_bib73","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(12)61855-8","article-title":"Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial","volume":"381","author":"Teerlink","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2014.09.032_bib74","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ejhf.74","article-title":"Decongestion in acute heart failure","volume":"16","author":"Mentz","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2014.09.032_bib75","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.cjca.2012.10.007","article-title":"The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure","volume":"29","author":"McKelvie","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2014.09.032_bib76","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2217\/fca.12.54","article-title":"Should torsemide be the loop diuretic of choice in systolic heart failure?","volume":"8","author":"DiNicolantonio","year":"2012","journal-title":"Future Cardiol"},{"key":"10.1016\/j.cjca.2014.09.032_bib77","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.jacc.2012.12.043","article-title":"Dominance of furosemide for loop diuretic therapy in heart failure: time to revisit the alternatives?","volume":"61","author":"Bikdeli","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.09.032_bib78","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2014.09.032_bib79","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/j.jacc.2011.10.910","article-title":"Diuretics and ultrafiltration in acute decompensated heart failure","volume":"59","author":"Felker","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.09.032_bib80","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jama.297.12.1332","article-title":"Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials","volume":"297","author":"Gheorghiade","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2014.09.032_bib81","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijcard.2014.03.020","article-title":"Hypertonic saline with furosemide for the treatment of acute congestive heart failure: a systematic review and meta-analysis","volume":"173","author":"Gandhi","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2014.09.032_bib82","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJMoa1100356","article-title":"Coronary-artery bypass surgery in patients with left ventricular dysfunction","volume":"364","author":"Velazquez","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2014.09.032_bib83","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jacc.2014.04.064","article-title":"Extent of coronary and myocardial disease and benefit from surgical revascularization in LV dysfunction","volume":"64","author":"Panza","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.09.032_bib84","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJMoa1100358","article-title":"Myocardial viability and survival in ischemic left ventricular dysfunction","volume":"364","author":"Bonow","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2014.09.032_bib85","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/1745-6215-14-218","article-title":"Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) IMAGE HF Project I-A: study protocol for a randomized controlled trial","volume":"14","author":"O'Meara","year":"2013","journal-title":"Trials"},{"key":"10.1016\/j.cjca.2014.09.032_bib86","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa0900559","article-title":"Coronary bypass surgery with or without surgical ventricular reconstruction","volume":"360","author":"Jones","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2014.09.032_bib87","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jtcvs.2012.09.007","article-title":"Insights from the STICH trial: change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction","volume":"146","author":"Michler","year":"2013","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cjca.2014.09.032_bib88","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cjca.2013.11.022","article-title":"Functional mitral regurgitation: current understanding and approach to management","volume":"30","author":"Ducas","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2014.09.032_bib89","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1067\/mhj.2002.123575","article-title":"Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction","volume":"144","author":"Koelling","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2014.09.032_bib90","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/hrt.72.1.63","article-title":"Effect of captopril on functional mitral regurgitation in dilated heart failure: a randomised double blind placebo controlled trial","volume":"72","author":"Seneviratne","year":"1994","journal-title":"Br Heart J"},{"key":"10.1016\/j.cjca.2014.09.032_bib91","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0002-8703(00)90036-X","article-title":"Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol","volume":"139","author":"Capomolla","year":"2000","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2014.09.032_bib92","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jtcvs.2011.05.006","article-title":"Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial: a report from the Cardiothoracic Surgical Trials Network","volume":"143","author":"Smith","year":"2012","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cjca.2014.09.032_bib93","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1312808","article-title":"Mitral-valve repair versus replacement for severe ischemic mitral regurgitation","volume":"370","author":"Acker","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2014.09.032_bib94","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1009355","article-title":"Percutaneous repair or surgery for mitral regurgitation","volume":"364","author":"Feldman","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2014.09.032_bib95","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.ahj.2013.01.010","volume":"165","author":"Machaalany","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2014.09.032_bib96","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1161\/CIRCULATIONAHA.110.009803","article-title":"Cardiac resynchronization therapy as a therapeutic option in patients with moderate-severe functional mitral regurgitation and high operative risk","volume":"124","author":"van Bommel","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.09.032_bib97","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/CIRCINTERVENTIONS.113.000650","article-title":"Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A)","volume":"6","author":"Elmariah","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2014.09.032_bib98","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.cjca.2013.09.009","article-title":"Canadian Cardiovascular Society guidelines on the use of cardiac resynchronization therapy: implementation","volume":"29","author":"Parkash","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2014.09.032_bib99","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1161\/CIRCULATIONAHA.107.743120","article-title":"Results of the Predictors of Response to CRT (PROSPECT) trial","volume":"117","author":"Chung","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.09.032_bib100","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/eurheartj\/ehs454","article-title":"Cardiac resynchronization therapy: state of the art 2013","volume":"34","author":"Yu","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2014.09.032_bib101","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJM199711273372202","article-title":"A\u00a0comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators","volume":"337","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2014.09.032_bib102","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1161\/01.CIR.101.11.1297","article-title":"Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone","volume":"101","author":"Connolly","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.09.032_bib103","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/01.CIR.102.7.748","article-title":"Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH)","volume":"102","author":"Kuck","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.09.032_bib104","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2014.09.032_bib105","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJM199612263352601","article-title":"Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators","volume":"335","author":"Moss","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2014.09.032_bib106","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1056\/NEJM199912163412503","article-title":"A\u00a0randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators","volume":"341","author":"Buxton","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2014.09.032_bib107","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/CIRCULATIONAHA.113.002648","article-title":"Implantable cardioverter-defibrillator therapy before death: high risk for painful shocks at end of life","volume":"129","author":"Kinch Westerdahl","year":"2014","journal-title":"Circulation"},{"issue":"suppl R","key":"10.1016\/j.cjca.2014.09.032_bib108","doi-asserted-by":"crossref","first-page":"R122","DOI":"10.4244\/EIJV9SRA21","article-title":"Therapeutic potential of renal sympathetic denervation in patients with chronic heart failure","volume":"9","author":"Bohm","year":"2013","journal-title":"EuroIntervention"},{"key":"10.1016\/j.cjca.2014.09.032_bib109","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijcard.2012.09.019","article-title":"First-in-man safety evaluation of renal denervation for chronic systolic heart failure: primary outcome from REACH-Pilot study","volume":"162","author":"Davies","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2014.09.032_bib110","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/ejhf.138","article-title":"Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study","volume":"16","author":"Gronda","year":"2014","journal-title":"Eur J Heart Fail"},{"issue":"suppl B","key":"10.1016\/j.cjca.2014.09.032_bib111","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/eurheartj\/11.suppl_B.123","article-title":"Mechanisms of myocyte and capillary growth in the infarcted heart","volume":"11","author":"Anversa","year":"1990","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2014.09.032_bib112","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0033-0620(90)90039-5","article-title":"Ischemic cardiomyopathy: pathophysiologic mechanisms","volume":"33","author":"Anversa","year":"1990","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.cjca.2014.09.032_bib113","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nrcardio.2014.9","article-title":"Cell therapy for cardiac repair\u2013lessons from clinical trials","volume":"11","author":"Behfar","year":"2014","journal-title":"Nat Rev Cardiol"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X14014470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X14014470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T23:33:50Z","timestamp":1650324830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X14014470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":113,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0828282X14014470"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2014.09.032","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Epidemic of Heart Failure: A Lucid Approach to Stemming the Rising Tide","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2014.09.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}